Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Phagocytosis of photoreceptor outer segments by retinal pigment epithelium
EF 2023-24
Résumé
Our vision starts with the detection of light by light-sensitive cells at the back of the eyes called photoreceptors. Once formed, these cells do not divide, and are with us for life. To overcome the damage they accumulate from constant light exposure, they need to be renewed: old segments of photoreceptors must be removed to make room for new, undamaged segments. This process is achieved by phagocytosis, which means cell eating. The aged, damaged portions are phagocytosed, or eaten, by a specialized layer of cells right behind the photoreceptors called the retinal pigment epithelium (RPE). The RPE must then digest their meal. The compartments containing the photoreceptor segment becomes acidic and its contents are broken down and reused in a process called resolution. Impaired resolution in the RPE leads to the accumulation of undigested materials, and is strongly associated in degenerative retinal diseases like age-related macular degeneration (AMD), the leading cause of blindness in the developed world. Research in our lab has shown that treating cells with drugs that prevent harmful reactions with oxygen actually makes the resolution process more efficient. Additionally, we know that harmful reactions of the RPE and photoreceptors with oxygen is strongly implicated in degenerative retinal disease in people. As such, the purpose of my research is to determine a link between these two things: do harmful reactions with oxygen along the phagocytic pathway in RPE lead to the accumulation of lipofuscin and degenerative retinal disease? Finding an answer to this question may lead us to new therapeutic targets for AMD to treat blindness in patients suffering from the condition.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506453
Name
Kwon Whijin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Phagocytosis of photoreceptor outer segments by retinal pigment epithelium
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Degeneration; Lipofuscin; Oxidation; Phagocytosis; Resolution; Retina; Therapeutic Target
Abstract
Our vision starts with the detection of light by light-sensitive cells at the back of the eyes called photoreceptors. Once formed, these cells do not divide, and are with us for life. To overcome the damage they accumulate from constant light exposure, they need to be renewed: old segments of photoreceptors must be removed to make room for new, undamaged segments. This process is achieved by phagocytosis, which means cell eating. The aged, damaged portions are phagocytosed, or eaten, by a specialized layer of cells right behind the photoreceptors called the retinal pigment epithelium (RPE). The RPE must then digest their meal. The compartments containing the photoreceptor segment becomes acidic and its contents are broken down and reused in a process called resolution. Impaired resolution in the RPE leads to the accumulation of undigested materials, and is strongly associated in degenerative retinal diseases like age-related macular degeneration (AMD), the leading cause of blindness in the developed world. Research in our lab has shown that treating cells with drugs that prevent harmful reactions with oxygen actually makes the resolution process more efficient. Additionally, we know that harmful reactions of the RPE and photoreceptors with oxygen is strongly implicated in degenerative retinal disease in people. As such, the purpose of my research is to determine a link between these two things: do harmful reactions with oxygen along the phagocytic pathway in RPE lead to the accumulation of lipofuscin and degenerative retinal disease? Finding an answer to this question may lead us to new therapeutic targets for AMD to treat blindness in patients suffering from the condition.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kwon, Whijin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~